Spikogen
Showing 1 - 8 of 8
COVID-19 Trial in Adelaide (SpikoGen vaccine)
Not yet recruiting
- COVID-19
- SpikoGen vaccine
-
Adelaide, South Australia, AustraliaARASMI
Sep 13, 2022
COVID-19 Trial in Adelaide (Advax-CpG55.2 adjuvanted recombinant spike protein)
Recruiting
- COVID-19
- Advax-CpG55.2 adjuvanted recombinant spike protein
-
Adelaide, South Australia, AustraliaARASMI
Aug 15, 2022
Covid19 Trial in Tehran (SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant, Saline )
Completed
- Covid19
- SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
- Saline placebo
-
Tehran, Iran, Islamic Republic ofEspinas Palace Hotel
Oct 11, 2022
Covid19 Trial in Tehran (SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant, Saline )
Completed
- Covid19
- SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
- Saline placebo
-
Tehran, Iran, Islamic Republic ofEspinas Palace Hotel
Oct 11, 2022
COVID-19 Trial in Adelaide (Spikogen/Covax-19)
Active, not recruiting
- COVID-19
- Spikogen/Covax-19
-
Adelaide, South Australia, AustraliaARASMI
May 12, 2022
COVID-19 Trial in Tehran (SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant)
Recruiting
- COVID-19
- SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
-
Tehran, Iran, Islamic Republic ofShaheed Labbafinezhad Hospital
Mar 9, 2022
COVID-19 Trial in Tehran (Low-dose SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant, SARS-CoV-2 recombinant spike
Completed
- COVID-19
- Low-dose SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
- SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
-
Tehran, Iran, Islamic Republic ofOrchid Life Department, Orchid Pharmed Company
Oct 13, 2022
COVID-19 Trial in Tehran (SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant, Saline )
Active, not recruiting
- COVID-19
- SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
- Saline placebo
-
Tehran, Iran, Islamic Republic ofOrchid Life Department, Orchid Pharmed Company
Jan 3, 2022